Study Stopped
End of funding period
Non-invasive Objective Assessment of Hemodynamics in Preterm Neonates
NOAH
1 other identifier
observational
56
1 country
1
Brief Summary
Study type: Prospective Observational trial Study design: Longitudinal Population: Preterm newborns \<32 weeks gestational age Hypothesis: The inclusion of non-invasive physiological measures of cardiac output, peripheral perfusion and brain oxygenation (NIRS) for preterm neonates is feasible and reveals additional information on the hemodynamic status compared to blood pressure alone. These measurements can improve the ability to rapidly identify those infants who might benefit from intervention and are correlated with short term clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 9, 2019
CompletedFirst Submitted
Initial submission to the registry
March 5, 2020
CompletedFirst Posted
Study publicly available on registry
September 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2021
CompletedJanuary 27, 2023
January 1, 2023
1.6 years
March 5, 2020
January 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adverse Outcome of Circulatory Failure
Correlation of clinical, laboratory, conventional and multimodal non-invasive monitoring and/or a combination of variables with ultrasound abnormality (IVH grade 3 - 4/any IVH) or death within the first two weeks of life.
14 days
Secondary Outcomes (14)
Feasibility of non-invasive Cardiac Output Monitoring and Pulsatility Index
48 hours
Reproducibility of absolute left ventricular cardiac output estimated by echocardiography compared to cardiac output estimated by non-invasive Cardiac Output Monitoring
48 hours
Reproducibility of left ventricular cardiac output indexed to bodyweight estimated by echocardiography compared to cardiac output estimated by non-invasive Cardiac Output Monitoring
48 hours
Reproducibility of left ventricular stroke volume estimated by echocardiography compared to cardiac output estimated by non-invasive Cardiac Output Monitoring
48 hours
Reproducibility of absolute right ventricular cardiac output indexed to bodyweight estimated by echocardiography compared to cardiac output estimated by non-invasive Cardiac Output Monitoring
48 hours
- +9 more secondary outcomes
Other Outcomes (6)
Burden of clinical suspicion indicating Circulatory Insufficiency
48 hours
Burden of Laboratory parameters indicating Circulatory Insufficiency
48 hours
Burden and Onset of Hypotension indicating Circulatory Insufficiency
48 hours
- +3 more other outcomes
Study Arms (2)
Feasibility/Accuracy/Reproducibility
The first 20 participants will be analysed for feasibility and the first 40 ECHOs for accuracy/reproducibility of non-invasive Cardiac Output Monitoring with ECHO as reference Method.
Prediction of Circulatory Failure
Together with the Feasibility/Accuracy/Reproducibility Cohort this group's results will be analysed for prediction of circulatory failure defined as an ultrasound abnormality (IVH grade 3 - 4) or death within the first two weeks of life.
Interventions
Multimodal objective non-invasive monitoring including cerebral oxygenation (NIRS), pulse oximetry with Pulsatility Index (PI) and non-invasive Cardiac Output Monitoring will be recorded but not used for clinical decision making. 2 ECHOs will be performed (one within the first 24h, one in the 2nd 24 hours after birth)
Eligibility Criteria
Preterm Neonates born at a gestational age of 23 weeks 0 days to 31 weeks 6 days.
You may qualify if:
- Neonates of 23 weeks 0 days to 31 weeks 6 days
- NIRS/non-invasive Cardiac Output - device available
- Parental Informed Consent
You may not qualify if:
- Congenital anomalies
- Major cardiac defects
- Hydrops
- Parents decline to consent to the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Neonatal Unit Cork University Maternity Hospital
Cork, Ireland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eugene M Dempsey, MD
UCC
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 5, 2020
First Posted
September 3, 2020
Study Start
November 9, 2019
Primary Completion
May 31, 2021
Study Completion
May 31, 2021
Last Updated
January 27, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share